首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.
【24h】

Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.

机译:术中溢出有利的组织学浸润肿瘤细胞:放射线和化学疗法对腹部复发的影响。国家威尔姆斯肿瘤研究小组的报告。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: We undertook this study to determine (1) the frequency with which spilled tumor cells of favorable histology produced intra-abdominal disease in patients treated with differing chemotherapy regimens and abdominal radiation therapy (RT) and (2) the patterns of relapse and outcomes in such patients. METHODS AND MATERIALS: The influence of RT dose (0, 10, and 20 Gy), RT fields (flank, whole abdomen), and chemotherapy with dactinomycin and vincristine (2 drugs) vs. added doxorubicin (three drugs) on intra-abdominal tumor recurrence rates was analyzed by logistic regression in 450 patients. Each patient was considered at risk for two types of failure: flank and subdiaphragmatic beyond-flank recurrence, with the correlation between the two outcomes accounted for in the analyses. RESULTS: The crude odds ratio for the risk of recurrence relative to no RT was 0.35 (0.15-0.78) for 10Gy and 0.08 (0.01-0.58) for 20Gy. The odds ratio for the risk of recurrence for doxorubicin to two drugs after adjusting for RT was not significant. For Stage II patients (NWTS-4), the 8-year event rates with and without spillage, respectively, were 79% and 87% for relapse-free survival (p = 0.07) and 90% and 95% for overall survival (p = 0.04). CONCLUSIONS: Irradiation (10 Gy or 20 Gy) reduced abdominal tumor recurrence rates after tumor spillage. Tumor spillage in Stage II patients reduced relapse-free survival and overall survival, but only the latter was of statistical significance. These data provide a basis for assessing the risks vs. benefits when considering treatment for children with favorable histology Wilms tumor and surgical spillage.
机译:目的:我们进行了这项研究,以确定(1)接受不同化学疗法和腹部放射治疗(RT)的患者中,具有良好组织学特征的溢出肿瘤细胞发生腹腔疾病的频率,以及(2)复发的模式和结果在这样的病人中。方法和材料:放疗剂量(0、10和20 Gy),放疗区域(后腹,整个腹部)以及放线菌素和长春新碱(2种药物)与加阿霉素(三种药物)的化疗对腹腔内的影响通过logistic回归分析450例患者的肿瘤复发率。每个患者都被认为有两种类型的失败风险:侧腹和dia下亚侧复发,分析中考虑了两种结果之间的相关性。结果:相对于无RT,复发风险的粗略优势比为10Gy为0.35(0.15-0.78),而20Gy为0.08(0.01-0.58)。调整RT后,阿霉素与两种药物复发风险的比值比不显着。对于II期患者(NWTS-4),无复发生存的8年事件发生率(无溢漏)和无溢漏发生的8年事件发生率分别为79%和87%(p = 0.07)和总体生存率分别为90%和95%(p = 0.04)。结论:辐射(10 Gy或20 Gy)可降低肿瘤溢出后腹部肿瘤的复发率。 II期患者的肿瘤溢漏降低了无复发生存期和总体生存期,但只有后者具有统计学意义。这些数据为评估具有良好组织学Wilms肿瘤和手术溢漏的儿童进行治疗时评估风险与获益之间的关系提供了基础。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号